INTERNATIONAL PATENT: TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED, 泰励生物科技（上海）有限公司 FILES APPLICATION FOR "COMPOUND HAVING ANTI-KRAS MUTANT TUMOR ACTIVITY"

GENEVA, Jan. 27 -- TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED (5/F, Building 1B, 3728 Jinke Road, Pudong New AreaShanghai 201203), 泰励生物科技（上海）有限公司 (中国上海市浦东新区金科路3728号1号楼B栋5层) filed a patent application (PCT/CN2024/106147) for "COMPOUND HAVING ANTI-KRAS MUTANT TUMOR ACTIVITY" on Jul 18, 2024. With publication no. WO/2025/016432, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the W...